Diagnosis and Management of Cognitive Dysfunction In Systemic Lupus Erythematosus Patients
DOI:
https://doi.org/10.21776/ub.crjim.2022.003.01.6Keywords:
cognitive disorders, SLE, NPSLE.Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with diverse clinical manifestations. One of the frequent manifestations of SLE is cognitive dysfunction. Cognitive dysfunction is a hidden and often undiagnosed manifestation of SLE but can severely impair quality of life even in mild cognitive dysfunction. Early detection of cognitive dysfunction in SLE patients can determine interventions to help patients adapt to the effects of this decline in cognitive function. However, currently, screening and diagnosis of cognitive dysfunction in SLE are often delayed, and monitoring cannot be done properly. This may be due to the most appropriate assessment tool for cognitive screening in SLE patients has not been agreed upon. The management of cognitive dysfunction in SLE patients today is still challenging due to the SLE pathophysiology is still in debate and research. This literature review will discuss the approach of diagnosis and management of cognitive dysfunction in SLE.
References
Al Rayes H, Tani C, Kwan A, et al. What is the prevalence of cognitive dysfunction in lupus and which instruments are used to measure it? A systematic review and meta-analysis. In Seminars in arthritis and rheumatism 2018 Oct 1 (Vol. 48, No. 2, pp. 240-255).
WB Saunders. Ho RC, Husain SF, et al. Cognitive dysfunction in patients with systemic lupus erythematosus: The challenge in diagnosis and management. Rheumatology Practice and Research. 2018 Aug;3:2059902118792434.
Kello N, Anderson E, Diamond B. Cognitive dysfunction in systemic lupus erythematosus: a case for initiating trials. Arthritis & Rheumatology. 2019 Sep;71(9):1413-25.
Saepudin A, Ong PA, Hidayat S, et al. Correlation BetweenCognitive Function with Disease Activity of Systemic Lupus Erythematosus Patients in Dr. Hasan Sadikin Hospital Bandung: An Analytical Cross-Sectional Study. Indonesian Journal of Rheumatology. 2019 Jun 12;11(1).
Bland A, Hunziker S, Barraclough M, et al. PS6: 110 Motor and cognitive fatigue in sle is associated with mood and health-related quality of life (hrqol) in patients with sle: results from the patient reported outcomes in lupus (pro-lupus) study.2018
Appenzeller S, Cendes F, Costallat LT. Cognitive dysfunction and employment status in systemic lupus erythematosus: a prospective longitudinal study. Arthritis Care & Research: Official Journal of the American College of Rheumatology. 2009 May 15;61(5):680-7.
Johansson MM, Marcusson J, Wressle E. Cognitive impairment and its consequences in everyday life: experiences of people with mild cognitive impairment or mild dementia and their relatives. International Psychogeriatrics. Cambridge University Press; 2015;27(6):949–58.
Mikdashi JA. Proposed response criteria for neurocognitive dysfunction in systemic lupus erythematosus clinical trials. Lupus. 2007 Jun;16(6):418-25.
Liang MH, Corzillius M, Bae SC, et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis and rheumatism. 1999 Apr;42(4):599-608.
Nantes SG, Su J, Dhaliwal A, et al. Performance of screening tests for cognitive dysfunction in systemic lupus erythematosus. The Journal of rheumatology. 2017 Nov 1;44(11):1583-9.
Harvey PD. Domains of cognition and their assessment. Dialogues in clinical neuroscience. 2019 Sep;21(3):227.
Duarte-García, A., Romero-Díaz, J., et al. and Sánchez-Guerrero, J. Disease activity, autoantibodies, and inflammatory molecuSLE in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction. 2018. PloS one, 13(5), p.e0196487.
Barraclough, M., McKie, S., Parker, B., et al. Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes. Annals of the Rheumatic Diseases. 2019, 78(7),934–940. DOI:https://doi.org/10.1136/annrheumdis-2018-214677
Lillis TA, Tirone V, Gandhi N, et al. Sleep Disturbance and Depression Symptoms Mediate Relationship Between Pain and Cognitive Dysfunction in Lupus. Arthritis Care & Research. 2019 Mar;71(3):406-12.
Murray SG, Yazdany J, Kaiser R, et al. Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus. Arthritis care & research. 2012 Sep;64(9):1328-33.
Rogers JL, Eudy AM, Criscione-Schreiber LG, et al. 114 Features of fibromyalgia in lupus nephritis. 2019.
Plantinga L, Lim SS, Bowling CB, et al. Perceived stress and reported cognitive symptoms among Georgia patients with systemic lupus erythematosus. Lupus. 2017 Sep;26(10):1064-71.
Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nature Reviews Neurology. 2014 Oct;10(10):579-96.Mackay, M. (2015).
Mackay M. Lupus brain fog: a biologic perspective on cognitive dysfunction, depression, and fatigue in systemic lupus erythematosus. Immunologic research. 2015 Dec;63(1):26-37.
Tay SH, Fairhurst AM, Mak A. Clinical utility of circulating antiN-methyl-D-aspartate receptor subunits NR2A/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjögren’s syndrome: an updated meta-analysis. Autoimmun Rev 2017; 16:114–22.
Hirohata, S. ed., 2018. Neuropsychiatric Systemic Lupus Erythematosus: Pathogenesis, Clinical Aspects and Treatment. Springer.
Segovia‐Miranda F, Serrano F, Dyrda A, et al. Pathogenicity of Lupus Anti–Ribosomal P Antibodies: Role of Cross‐Reacting Neuronal Surface P Antigen in Glutamatergic Transmission and Plasticity in a Mouse Model. Arthritis & rheumatology. 2015 Jun;67(6):1598-610.
Yelnik CM, Kozora E, Appenzeller S. Cognitive disorders and antiphospholipid antibodies. Autoimmun Rev 2016; 15:1193–8.
Bialas AR, Presumey J, Das A, et al. Microglia-dependent synapse loss in type I interferon-mediated lupus. Nature 2017; 546:539–43.
Monteiro S, Ferreira FM, Pinto V, et al. Absence of IFNγ promotes hippocampal plasticity and enhances cognitive performance. Translational psychiatry. 2016 Jan;6(1):e707
Korte-Bouws GA, Albers E, Voskamp M, et al. Juvenile arthritis patients suffering from chronic inflammation have increased activity of both IDO and GTP-CH1 pathways but decreased BH4 efficacy: implications for well-being, including fatigue, cognitive dysfunction, anxiety, and depression. Pharmaceuticals. 2019 Mar;12(1):9.Stock AD, Wen J, Putterman C. Neuropsychiatric lupus, the blood-brain barrier, and the TWEAK/Fn14 pathway. Front Immunol 2013; 4:484.
Stock AD, Wen J, Putterman C. Neuropsychiatric lupus, the blood-brain barrier, and the TWEAK/Fn14 pathway. Front Immunol 2013; 4:484.
Kwieciński J, Kłak M, Trysberg E, et al. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2009; 60:2094–101.
Nestor J, Arinuma Y, Huerta TS, et al. Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors. Journal of Experimental Medicine. 2018 Oct 1;215(10):2554-66.
Yoshio T, Onda K, Nara H, et al. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2006; 54:675–81.
Mahajan SD, Tutino VM, Redae Y, et al. C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology 2016; 148:407–
Duarte-Delgado NP, Vasquez G, Ortiz-Reyes BL. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus. Autoimmunity reviews. 2019 Apr 1;18(4):426-32.
Ainiala H, Hietaharju A, Dastidar P, et al. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance abnormalities. Arthritis Rheum 2004; 50:858–65
Ulfah, F., Octaviani, H., Handono, K., et al. (2019, June). T cell senescence and its correlation to inflammaging process of patients with systemic lupus erythematosus. In AIP Conference Proceedings (Vol. 2108, No. 1, p. 020031). AIP Publishing LLC.
Kuznetsov AW, Anisman H. eds., 2013. The Wiley-Blackwell handbook of psychoneuroimmunology. Oxford: Wiley-Blackwell.
Schwartz N, Stock AD, Putterman C. 2019. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nature Reviews Rheumatology, 15(3), pp.137-152.
Chávez-Castillo, M., Rojas, M. and Bautista, J. Excitotoxicity: an organized crime at the cellular level. 2017. ARCHIVOS DE MEDICINA, 8(3), p.193.
Ueno M, Chiba Y, Murakami R, et al. Disturbance of Intracerebral Fluid Clearance and Blood-Brain Barrier in Vascular Cognitive dysfunction. International journal of molecular sciences. 2019 Jan;20(10):2600.
Vargas JV. Evaluation of central nervous system involvement in SLE patients. Screening psychiatric manifestations-a systematic review. 2012.
Kozora E, Ellison MC, West S. Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum. 2004 Oct 15;51(5):810-8. DOI: 10.1002/art.20692. PMID: 15478145.
Larner, A. J. Cognitive Screening Instruments. 2017. (A. J. Larner (ed.); second). https://doi.org/10.1007/978-3-319-44775-9
Kabátová, O., Puteková, S., Martinková, J. et al. Analysis of psychometric features of the Mini-Mental State Examination and the Montreal Cognitive Assessment methods. 2016. Clin Soc Work Health Interv, 7(2), pp.62-69.
Julian LJ, Yazdany J, Trupin L, et al. Validity of brief screening tools for cognitive dysfunction in rheumatoid arthritis and systemic lupus erythematosus. Arthritis care & research. 2012 Mar;64(3):448-54.
Petri M, Naqibuddin M, Sampedro M, et al. Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial. InSeminars in arthritis and rheumatism 2011 Oct 1 (Vol. 41, No. 2, pp. 194-202). WB Saunders.
McLaurin EY, Holliday SL, Williams P, et al. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005 ;64:297–303
Navarrete-Navarrete, N., Peralta-Ramírez, M.I., Sabio-Sánchez, J.M., Coín, et al. Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial. 2010. Psychotherapy and psychosomatics, 79(2), pp.107-115.
Mak, A., Ho, R.C.M. and Lau, C.S. Clinical implications of neuropsychiatric systemic lupus erythematosus. Advances in psychiatric treatment. 2009, 15(6), pp.451-458.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Clinical and Research Journal in Internal Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the journal as the publisher of the journal. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
